Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Large-scale testing (Phase 3)Ended earlyNCT02129699What this trial is testingSurvival imProvement in Lung cancEr iNduced by DenOsUmab theRapyWho this might be right forLung Cancer Non-small Cell Stage IV ETOP IBCSG Partners Foundation 595
Testing effectiveness (Phase 2)Study completedNCT05104567What this trial is testingSAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)Who this might be right forOesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more Sanofi 138
Not applicableStudy completedNCT02323555What this trial is testingOptimize the Requirements and Preparations in Outpatient ChemotherapyWho this might be right forCancerIV Anticancer Therapy Centre Francois Baclesse 624
Not applicableLooking for participantsNCT06713993What this trial is testingSemmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction CancerWho this might be right forEsophageal Cancer (EsC) Semmelweis University 100
Not applicableStudy completedNCT04168814What this trial is testingNutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) StudyWho this might be right forMalnutritionOncologic ComplicationsOncology+1 more Universidad Pontificia Comillas 586
Large-scale testing (Phase 3)Looking for participantsNCT06338683What this trial is testingSurvival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung CancerWho this might be right forAdvanced CancerOlanzapineProgression Free Survival Qinghai Red Cross Hospital 230
Early research (Phase 1)Looking for participantsNCT06233942What this trial is testingPhase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BeOne Medicines 308
Not applicableLooking for participantsNCT06317389What this trial is testingPACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of TreatmentsWho this might be right forCancerOncologyOncoral Program Hospices Civils de Lyon 3,000
Not applicableStudy completedNCT04583124What this trial is testingAdjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)Who this might be right forBreast Neoplasm Universidad de Granada 42
Not applicableStudy completedNCT02383576What this trial is testingRetrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223Who this might be right forBreast Cancer Hoffmann-La Roche 185
Testing effectiveness (Phase 2)Looking for participantsNCT07227415What this trial is testingSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerWho this might be right forCarcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more Pfizer 224
Early research (Phase 1)Active Not RecruitingNCT06052306What this trial is testingLearn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forMetastatic Castration-resistant Prostate Cancer Bayer 232
Testing effectiveness (Phase 2)Temporarily pausedNCT06050252What this trial is testingTesting the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before SurgeryWho this might be right forResectable Intrahepatic Cholangiocarcinoma National Cancer Institute (NCI) 27
Not applicableStudy completedNCT03952312What this trial is testingOncotool for Cancer MedicationsWho this might be right forCancerCancer, Treatment-RelatedMedication Adherence+2 more Northwestern University 83
Early research (Phase 1)WithdrawnNCT06719973What this trial is testingPhase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)Who this might be right forAdvanced Solid Tumors EMD Serono Research & Development Institute, Inc.
Early research (Phase 1)Looking for participantsNCT07391670What this trial is testingA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabWho this might be right forSolid Tumours AstraZeneca 40
Not applicableNot Yet RecruitingNCT07621289What this trial is testingRisk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in EuropeWho this might be right forCancerAnticancer TreatmentCardiovascular Disease Risk Factor+2 more University Hospital, Caen 10,000
Not applicableUnknownNCT04142463What this trial is testingCollaborative Network to Take Responsibility for Oral Anticancer Therapy 2Who this might be right forOncologic Disorders Ilyse Kenis 500
Testing effectiveness (Phase 2)Study completedNCT01529112What this trial is testingA Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different TreatmentsWho this might be right forNon-Small Cell Lung Cancer Eisai Inc. 135